Quarterly Results: Syncom Formulations (India) Limited reported its excellent performance for 4th quarter and year ended 31st March 25 Mumbai 29th May 2025:– Syncom Formulation ( India ) Ltd , a Speciality Pharmaceutical Formulation company reported its excellent performance for 4th quarter and year ended 31st March 25. Q4 FY2025 Performance highlights (compared to Q4 FY2024): Revenue from operations at Rs.14888 Lacs against Rs.7457 Lacs.; up 100%. EBITDA at Rs.2469 Lacs against Rs.1252 […]
The post Syncom Formulations Delivers Strong Q4 and Full-Year FY25 Results first appeared on Business News Week.